
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $7.4B | $8.2B | $8.8B | $10.5B | $10.4B | |
Revenue Growth (YoY) | -12.88% | 10.51% | 7.44% | 18.47% | -0.81% | |
Cost of Revenues | $6.2B | $6.7B | $7.4B | $8.7B | $8.5B | |
Gross Profit | $1.2B | $1.5B | $1.4B | $1.8B | $1.9B | |
Gross Profit Margin | 16.75% | 18.36% | 15.79% | 17.39% | 18.55% | |
R&D Expenses | $376M | $391M | $390M | $425M | $398M | |
Selling, General & Admin | $389M | $432M | $440M | $500M | $530M | |
Other Inc / (Exp) | -$23M | -$4M | -$2M | $2M | -$9M | |
Operating Expenses | $865M | $836M | $737M | $1.1B | $947M | |
Operating Income | $382M | $675M | $659M | $690M | $980M | |
Net Interest Expenses | $68M | $56M | $54M | $80M | $95M | |
EBT. Incl. Unusual Items | $291M | $614M | $603M | $612M | $875M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $103M | $177M | $178M | $123M | $227M | |
Net Income to Company | $188M | $437M | $425M | $489M | $648M | |
Minority Interest in Earnings | -$1M | -$2M | -$2M | -$1M | -$1M | |
Net Income to Common Excl Extra Items | $187M | $435M | $423M | $488M | $646M | |
Basic EPS (Cont. Ops) | $2.14 | $4.97 | $4.86 | $5.74 | $8.06 | |
Diluted EPS (Cont. Ops) | $2.14 | $4.96 | $4.85 | $5.72 | $8.04 | |
Weighted Average Basic Share | $87.3M | $87.5M | $87.1M | $85M | $80.2M | |
Weighted Average Diluted Share | $87.5M | $87.7M | $87.2M | $85.2M | $80.4M | |
EBITDA | $735M | $1.1B | $1B | $1.1B | $1.4B | |
EBIT | $364M | $674M | $663M | $705M | $983M | |
Revenue (Reported) | $7.4B | $8.2B | $8.8B | $10.5B | $10.4B | |
Operating Income (Reported) | $382M | $675M | $659M | $690M | $980M | |
Operating Income (Adjusted) | $364M | $674M | $663M | $705M | $983M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.2B | $2.1B | $2.5B | $2.6B | $2.6B | |
Revenue Growth (YoY) | 21.45% | -5.22% | 17.32% | 4.89% | -1.42% | |
Cost of Revenues | $1.8B | $1.8B | $2.1B | $2.2B | $2.1B | |
Gross Profit | $458M | $288M | $379M | $443M | $478M | |
Gross Profit Margin | 20.43% | 13.55% | 15.2% | 16.94% | 18.54% | |
R&D Expenses | $107M | $107M | $116M | $113M | $95M | |
Selling, General & Admin | $108M | $115M | $132M | $132M | $145M | |
Other Inc / (Exp) | -$4M | -$3M | $2M | $1M | $1M | |
Operating Expenses | $222M | $153M | $252M | $249M | $225M | |
Operating Income | $236M | $135M | $127M | $194M | $253M | |
Net Interest Expenses | $15M | $12M | $17M | $21M | $23M | |
EBT. Incl. Unusual Items | $217M | $119M | $109M | $174M | $233M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $60M | $36M | $34M | $47M | $65M | |
Net Income to Company | $157M | $83M | $74M | $127M | $167M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $157M | $83M | $74M | $126M | $167M | |
Basic EPS (Cont. Ops) | $1.79 | $0.95 | $0.86 | $1.53 | $2.15 | |
Diluted EPS (Cont. Ops) | $1.79 | $0.94 | $0.86 | $1.52 | $2.14 | |
Weighted Average Basic Share | $87.4M | $87.5M | $86.1M | $82.3M | $77.6M | |
Weighted Average Diluted Share | $87.6M | $87.8M | $86.3M | $83M | $77.9M | |
EBITDA | $332M | $227M | $220M | $296M | $353M | |
EBIT | $233M | $132M | $128M | $200M | $258M | |
Revenue (Reported) | $2.2B | $2.1B | $2.5B | $2.6B | $2.6B | |
Operating Income (Reported) | $236M | $135M | $127M | $194M | $253M | |
Operating Income (Adjusted) | $233M | $132M | $128M | $200M | $258M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.8B | $8.1B | $9.2B | $10.6B | $10.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.5B | $6.8B | $7.7B | $8.7B | $8.4B | |
Gross Profit | $1.4B | $1.3B | $1.5B | $1.9B | $2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $381M | $392M | $399M | $422M | $380M | |
Selling, General & Admin | $403M | $440M | $456M | $501M | $543M | |
Other Inc / (Exp) | -$20M | -$3M | $3M | $3M | -$8M | |
Operating Expenses | $889M | $769M | $834M | $1.1B | $923M | |
Operating Income | $485M | $572M | $652M | $756M | $1B | |
Net Interest Expenses | $69M | $52M | $59M | $83M | $96M | |
EBT. Incl. Unusual Items | $397M | $516M | $593M | $677M | $934M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $127M | $153M | $176M | $136M | $245M | |
Net Income to Company | $270M | $363M | $416M | $542M | $688M | |
Minority Interest in Earnings | -$1M | -$1M | -$2M | -$1M | -- | |
Net Income to Common Excl Extra Items | $269M | $362M | $414M | $540M | $686M | |
Basic EPS (Cont. Ops) | $3.08 | $4.14 | $4.78 | $6.43 | $8.71 | |
Diluted EPS (Cont. Ops) | $3.06 | $4.12 | $4.78 | $6.41 | $8.69 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $851M | $963M | $1B | $1.2B | $1.4B | |
EBIT | $470M | $573M | $659M | $777M | $1B | |
Revenue (Reported) | $7.8B | $8.1B | $9.2B | $10.6B | $10.4B | |
Operating Income (Reported) | $485M | $572M | $652M | $756M | $1B | |
Operating Income (Adjusted) | $470M | $573M | $659M | $777M | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.2B | $2.1B | $2.5B | $2.6B | $2.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.8B | $1.8B | $2.1B | $2.2B | $2.1B | |
Gross Profit | $458M | $288M | $379M | $443M | $478M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $107M | $107M | $116M | $113M | $95M | |
Selling, General & Admin | $108M | $115M | $132M | $132M | $145M | |
Other Inc / (Exp) | -$4M | -$3M | $2M | $1M | $1M | |
Operating Expenses | $222M | $153M | $252M | $249M | $225M | |
Operating Income | $236M | $135M | $127M | $194M | $253M | |
Net Interest Expenses | $15M | $12M | $17M | $21M | $23M | |
EBT. Incl. Unusual Items | $217M | $119M | $109M | $174M | $233M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $60M | $36M | $34M | $47M | $65M | |
Net Income to Company | $157M | $83M | $74M | $127M | $167M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $157M | $83M | $74M | $126M | $167M | |
Basic EPS (Cont. Ops) | $1.79 | $0.95 | $0.86 | $1.53 | $2.15 | |
Diluted EPS (Cont. Ops) | $1.79 | $0.94 | $0.86 | $1.52 | $2.14 | |
Weighted Average Basic Share | $87.4M | $87.5M | $86.1M | $82.3M | $77.6M | |
Weighted Average Diluted Share | $87.6M | $87.8M | $86.3M | $83M | $77.9M | |
EBITDA | $332M | $227M | $220M | $296M | $353M | |
EBIT | $233M | $132M | $128M | $200M | $258M | |
Revenue (Reported) | $2.2B | $2.1B | $2.5B | $2.6B | $2.6B | |
Operating Income (Reported) | $236M | $135M | $127M | $194M | $253M | |
Operating Income (Adjusted) | $233M | $132M | $128M | $200M | $258M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $969M | $594M | $498M | $330M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.8B | $1.7B | $1.9B | $2.2B | $2B | |
Inventory | $798M | $777M | $969M | $1B | $921M | |
Prepaid Expenses | $164M | $164M | -- | -- | $167M | |
Other Current Assets | $263M | $20M | $29M | $33M | $34M | |
Total Current Assets | $4.3B | $3.7B | $3.7B | $4B | $3.5B | |
Property Plant And Equipment | $2B | $2B | $2.1B | $2.4B | $2.4B | |
Long-Term Investments | $9M | $11M | $12M | $11M | $13M | |
Goodwill | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
Other Intangibles | $14M | $8M | $7M | $7M | $7M | |
Other Long-Term Assets | $44M | $51M | $40M | $64M | $61M | |
Total Assets | $8.2B | $7.5B | $7.7B | $8.3B | $7.8B | |
Accounts Payable | $1.2B | $1.1B | $1.7B | $2B | $1.8B | |
Accrued Expenses | $1.3B | $987M | $915M | $1.1B | $1.1B | |
Current Portion Of Long-Term Debt | $275M | $332M | $711M | $538M | $297M | |
Current Portion Of Capital Lease Obligations | $37M | $38M | $39M | $39M | $41M | |
Other Current Liabilities | $186M | $216M | $209M | $223M | $230M | |
Total Current Liabilities | $3.1B | $2.8B | $3.6B | $4B | $3.6B | |
Long-Term Debt | $2.1B | $1.7B | $1.1B | $1.3B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.7B | $4.9B | $5.1B | $5.8B | $5.5B | |
Common Stock | $103M | $103M | $91M | $88M | $80M | |
Other Common Equity Adj | -$347M | -$408M | -$522M | -$496M | -$659M | |
Common Equity | $2.4B | $2.6B | $2.6B | $2.6B | $2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $14M | $15M | $13M | $13M | $10M | |
Total Equity | $2.4B | $2.6B | $2.6B | $2.6B | $2.3B | |
Total Liabilities and Equity | $8.2B | $7.5B | $7.7B | $8.3B | $7.8B | |
Cash and Short Terms | $1.2B | $969M | $594M | $498M | $330M | |
Total Debt | $2.4B | $2B | $1.8B | $1.9B | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.3B | $938M | $713M | $569M | $322M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.8B | $1.8B | $2.1B | $2.2B | $2.2B | |
Inventory | $856M | $913M | $986M | $997M | $913M | |
Prepaid Expenses | $183M | $170M | -- | -- | -- | |
Other Current Assets | $260M | $78M | $90M | $71M | $75M | |
Total Current Assets | $4.4B | $3.9B | $4.1B | $4B | $3.7B | |
Property Plant And Equipment | $1.9B | $2B | $2.2B | $2.4B | $2.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.4B | $1.4B | $1.4B | -- | -- | |
Other Intangibles | $14M | $7M | $7M | $1.4B | $1.4B | |
Other Long-Term Assets | $457M | $476M | $528M | $564M | $581M | |
Total Assets | $8.2B | $7.8B | $8.2B | $8.3B | $8.1B | |
Accounts Payable | $1.2B | $1.4B | $1.7B | $1.9B | $1.8B | |
Accrued Expenses | $1.3B | $1.1B | $969M | $1.1B | $1.1B | |
Current Portion Of Long-Term Debt | $275M | $324M | $545M | $297M | $300M | |
Current Portion Of Capital Lease Obligations | $38M | $38M | $41M | $41M | $42M | |
Other Current Liabilities | $321M | $253M | $258M | $323M | $326M | |
Total Current Liabilities | $3.2B | $3.1B | $3.5B | $3.7B | $3.8B | |
Long-Term Debt | $2B | $1.6B | $1.6B | $1.8B | $1.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.7B | $5.1B | $5.5B | $5.9B | $5.8B | |
Common Stock | $103M | $103M | $91M | $86M | $80M | |
Other Common Equity Adj | -$410M | -$393M | -$487M | -$537M | -$652M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $14M | $15M | $14M | $13M | $10M | |
Total Equity | $2.5B | $2.7B | $2.6B | $2.4B | $2.4B | |
Total Liabilities and Equity | $8.2B | $7.8B | $8.2B | $8.3B | $8.1B | |
Cash and Short Terms | $1.3B | $938M | $713M | $569M | $322M | |
Total Debt | $2.3B | $2B | $2.2B | $2.1B | $2.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $188M | $437M | $425M | $489M | $648M | |
Depreciation & Amoritzation | $371M | $394M | $363M | $378M | $387M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$415M | $283M | -$297M | -$213M | $114M | |
Change in Inventories | -$34M | -$19M | -$243M | -$22M | $28M | |
Cash From Operations | $849M | $754M | $713M | $982M | $1.1B | |
Capital Expenditures | $344M | $458M | $585M | $573M | $579M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$340M | -$454M | -$485M | -$569M | -$563M | |
Dividends Paid (Ex Special Dividend) | -$54M | -$165M | -$224M | -$225M | -$219M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.2B | -- | -- | $559M | $526M | |
Long-Term Debt Repaid | -$723M | -$295M | -$357M | -$533M | -$306M | |
Repurchase of Common Stock | -- | -- | -$115M | -$352M | -$552M | |
Other Financing Activities | -$1M | -$1M | -$2M | -$1M | -$4M | |
Cash From Financing | $160M | -$469M | -$531M | -$490M | -$680M | |
Beginning Cash (CF) | $445M | $1.2B | $969M | $594M | $498M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $669M | -$170M | -$302M | -$76M | -$184M | |
Ending Cash (CF) | $1.2B | $969M | $594M | $498M | $330M | |
Levered Free Cash Flow | $505M | $296M | $128M | $409M | $480M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $157M | $83M | $74M | $127M | $167M | |
Depreciation & Amoritzation | $99M | $95M | $92M | $96M | $95M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -$7M | -$190M | |
Change in Inventories | -- | -- | -- | -$8M | $22M | |
Cash From Operations | $186M | $70M | -$46M | $122M | $77M | |
Capital Expenditures | $94M | $112M | $144M | $140M | $102M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$93M | -$17M | -$143M | -$140M | -$93M | |
Dividends Paid (Ex Special Dividend) | -- | -$56M | -$57M | -$56M | -$54M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $47M | -- | $533M | $534M | $39M | |
Long-Term Debt Repaid | -$26M | -$10M | -- | -- | -- | |
Repurchase of Common Stock | -- | -$18M | -$42M | -$160M | -$50M | |
Other Financing Activities | -- | $1M | $1M | $1M | -$1M | |
Cash From Financing | $22M | -$74M | $300M | $92M | $57M | |
Beginning Cash (CF) | $1.2B | $969M | $594M | $498M | $330M | |
Foreign Exchange Rate Adjustment | -$39M | -$11M | $7M | -$3M | -$49M | |
Additions / Reductions | $115M | -$20M | $112M | $74M | $41M | |
Ending Cash (CF) | $1.3B | $938M | $713M | $569M | $322M | |
Levered Free Cash Flow | $92M | -$42M | -$190M | -$18M | -$25M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $270M | $363M | $416M | $542M | $688M | |
Depreciation & Amoritzation | $381M | $390M | $360M | $382M | $386M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $879M | $638M | $597M | $1.2B | $1B | |
Capital Expenditures | $349M | $476M | $617M | $569M | $541M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$345M | -$378M | -$611M | -$566M | -$516M | |
Dividends Paid (Ex Special Dividend) | -- | -$221M | -$225M | -$224M | -$217M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $724M | -$47M | $533M | $560M | $31M | |
Long-Term Debt Repaid | -$749M | -$279M | -- | -$533M | -$306M | |
Repurchase of Common Stock | -- | -$18M | -$139M | -$470M | -$442M | |
Other Financing Activities | -- | -- | -$2M | -$1M | -$6M | |
Cash From Financing | -$237M | -$565M | -$157M | -$698M | -$715M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $298M | -$305M | -$170M | -$114M | -$217M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $530M | $162M | -$20M | $581M | $473M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $157M | $83M | $74M | $127M | $167M | |
Depreciation & Amoritzation | $99M | $95M | $92M | $96M | $95M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -$7M | -$190M | |
Change in Inventories | -- | -- | -- | -$8M | $22M | |
Cash From Operations | $186M | $70M | -$46M | $122M | $77M | |
Capital Expenditures | $94M | $112M | $144M | $140M | $102M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$93M | -$17M | -$143M | -$140M | -$93M | |
Dividends Paid (Ex Special Dividend) | -- | -$56M | -$57M | -$56M | -$54M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $47M | -- | $533M | $534M | $39M | |
Long-Term Debt Repaid | -$26M | -$10M | -- | -- | -- | |
Repurchase of Common Stock | -- | -$18M | -$42M | -$160M | -$50M | |
Other Financing Activities | -- | $1M | $1M | $1M | -$1M | |
Cash From Financing | $22M | -$74M | $300M | $92M | $57M | |
Beginning Cash (CF) | $1.2B | $969M | $594M | $498M | $330M | |
Foreign Exchange Rate Adjustment | -$39M | -$11M | $7M | -$3M | -$49M | |
Additions / Reductions | $115M | -$20M | $112M | $74M | $41M | |
Ending Cash (CF) | $1.3B | $938M | $713M | $569M | $322M | |
Levered Free Cash Flow | $92M | -$42M | -$190M | -$18M | -$25M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.